02235.HK
MicroTech Medical (Hangzhou) Co., Ltd.
HKSE · Healthcare · Medical - Devices · CN
HKD 6.80
−4.76%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.1B | 660.8M | 345.6M | 248.3M | 173.5M |
| Cost of Revenue | 512.4M | 303.4M | 162.8M | 125.1M | 93.9M |
| Gross Profit | 628.7M | 357.4M | 182.8M | 123.2M | 79.7M |
| Operating Expenses | |||||
| R&D Expense | 143.4M | 76.3M | 76.6M | 70.1M | 30.6M |
| SG&A Expense | 544.7M | 170.0M | 151.7M | 161.5M | 159.0M |
| General & Admin Expense | 70.7M | 17.9M | 12.3M | 15.9M | 42.3M |
| Selling & Marketing Expense | 326.7M | 152.1M | 139.4M | 145.6M | 116.7M |
| Other Expenses | (120.2M) | 67.1M | 14.3M | 11.9M | 8.3M |
| Total Operating Expenses | 568.0M | 313.5M | 242.6M | 243.5M | 197.9M |
| Cost and Expenses | 1.1B | 616.8M | 408.1M | 368.6M | 291.8M |
| Operating Income (EBIT) | 60.7M | 44.0M | (62.5M) | (120.3M) | (32.2M) |
| Non-Operating | |||||
| Interest Income | 82.1M | 46.5M | 62.8M | 68.2M | 55.7M |
| Interest Expense | 875.6K | 446.0K | 676.4K | 313.2K | 147.0K |
| Net Interest Income | 81.3M | 46.1M | 61.9M | 67.9M | 55.5M |
| Other Non-Op Income/Expense | (4.8M) | (3.6M) | (690.0K) | (4.6M) | (2.8M) |
| Non-Operating Income (excl Interest) | 54.0M | 26.2M | 69.3M | 75.0M | 85.4M |
| EBT (Pre-Tax Income) | 55.9M | 40.4M | (63.1M) | (124.9M) | (35.0M) |
| Income Tax Expense | 334.6K | 249.0K | 31.0K | 163.6K | 1.5K |
| Bottom Line | |||||
| Net Income | 55.6M | 40.2M | (63.1M) | (125.0M) | (35.0M) |
| Earnings from Cont. Ops | 55.6M | 40.2M | (63.1M) | (125.0M) | (35.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 55.6M | 40.2M | (63.1M) | (125.0M) | (35.0M) |
| Per Share | |||||
| Basic EPS | HK$0.14 | HK$0.10 | (HK$0.15) | (HK$0.29) | (HK$0.08) |
| Diluted EPS | HK$0.14 | HK$0.10 | (HK$0.15) | (HK$0.29) | (HK$0.08) |
| Revenue Per Share | HK$2.71 | HK$1.65 | HK$0.82 | HK$0.58 | HK$0.41 |
| Shares | |||||
| Basic Shares Outstanding | 421.1M | 401.5M | 420.8M | 425.7M | 425.7M |
| Diluted Shares Outstanding | 421.1M | 401.5M | 420.8M | 425.7M | 425.7M |
| Profitability Metrics | |||||
| EBITDA | 20.6M | 29.0M | (121.4M) | (184.1M) | (110.2M) |
| D&A | 13.9M | 11.2M | 10.4M | 11.2M | 10.1M |
| EBIT | 6.7M | 17.8M | (131.8M) | (195.3M) | (120.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026